MENU

STOK Stoke Therapeutics Forecast, Technical & Fundamental Analysis

a company, which engages in the research and development of treatments for genetic diseases.

Industry Biotechnology
STOK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
STOK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

STOK is expected to report earnings to rise 16.76% to -53 cents per share on November 13

Stoke Therapeutics STOK Stock Earnings Reports
Q3'24
Est.
$-0.54
Q2'24
Beat
by $0.09
Q1'24
Beat
by $0.05
Q4'23
Beat
by $0.04
Q3'23
Beat
by $0.08
The last earnings report on August 07 showed earnings per share of -46 cents, beating the estimate of -54 cents. With 149.42K shares outstanding, the current market capitalization sits at 646.51M.
A.I. Advisor
published General Information

General Information

a company, which engages in the research and development of treatments for genetic diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
45 Wiggins Avenue
Phone
+1 781 430-8200
Employees
110
Web
https://www.stoketherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY577.99-5.33
-0.91%
SPDR® S&P 500® ETF Trust
BTC.X66432.195000-929.210940
-1.38%
Bitcoin cryptocurrency
GME20.54-0.39
-1.86%
GameStop Corp
TSLA213.65-4.32
-1.98%
Tesla
AAPL230.76-5.10
-2.16%
Apple

STOK and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with NUVB. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then NUVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
-3.67%
NUVB - STOK
50%
Loosely correlated
-3.32%
QTTB - STOK
48%
Loosely correlated
+2.31%
STRO - STOK
46%
Loosely correlated
-0.85%
INZY - STOK
44%
Loosely correlated
-4.11%
NTLA - STOK
40%
Loosely correlated
-5.41%
More